Melek C. Arkan
- Immunology top 2%
- Immune Response and Inflammation 4
- Cancer Research top 2%
- NF-κB Signaling Pathways 7
- Oncology top 5%
- Cytokine Signaling Pathways and Interactions 4
- Epidemiology top 2%
- Physiology top 2%
- Diet and metabolism studies 3
-
- Gut microbiota and health 3
- Genomics, phytochemicals, and oxidative stress 1
- RNA regulation and disease 1
-
- Cholesterol and Lipid Metabolism 2
- Co-authors
- Florian R. GretenMichael KarinGiuseppe PoliJerrold M. OlefskyJeffrey M. LongShin MaedaAnthony Wynshaw‐BorisZhi-Wei Li
- Cited by
- ImmunologyCancer ResearchOncology
- Partner nations
- GermanyUnited StatesTürkiye
In The Last Decade
Melek C. Arkan
18 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Immunology 1.2k
- Cancer Research 792
- Oncology 964
- Epidemiology 1.1k
- Physiology 823
Countries citing papers authored by Melek C. Arkan
This map shows the geographic impact of Melek C. Arkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melek C. Arkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melek C. Arkan more than expected).
Fields of papers citing papers by Melek C. Arkan
This network shows the impact of papers produced by Melek C. Arkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melek C. Arkan. The network helps show where Melek C. Arkan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Melek C. Arkan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 7 | |
| 2 | 2024 | 3 | |
| 3 | 2022 | 53 | |
| 4 | 2017 | 16 | |
| 5 | 2014 | 18 | |
| 6 | 2014 | 343 | |
| 7 | 2010 | 42 | |
| 8 | 2010 | 144 | |
| 9 | 2010 | 85 | |
| 10 | 2009 | 143 | |
| 11 | gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesisbreakdown → | 2009 | 780 |
| 12 | 2008 | 139 | |
| 13 | NF-κB Is a Negative Regulator of IL-1β Secretion as Revealed by Genetic and Pharmacological Inhibition of IKKβbreakdown → | 2007 | 503 |
| 14 | 2006 | 37 | |
| 15 | IKK-β links inflammation to obesity-induced insulin resistancebreakdown → | 2005 | 1456 |
| 16 | 2001 | 21 | |
| 17 | 2001 | 59 | |
| 18 | 2000 | 174 |
About Melek C. Arkan
Melek C. Arkan is a scholar working on Cancer Research, Biological Psychiatry and Immunology, having authored 18 papers that have together received 4.0k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (7 papers), Immune Response and Inflammation (4 papers), Cytokine Signaling Pathways and Interactions (4 papers), Diet and metabolism studies (3 papers), Gut microbiota and health (3 papers), Cholesterol and Lipid Metabolism (2 papers), Genomics, phytochemicals, and oxidative stress (1 paper) and RNA regulation and disease (1 paper). The work is most often cited by research in Immunology (1.2k citations), Cancer Research (792 citations) and Oncology (964 citations). Melek C. Arkan has collaborated with scholars based in Germany, United States and Türkiye. Frequent co-authors include Florian R. Greten, Michael Karin, Giuseppe Poli, Jerrold M. Olefsky, Jeffrey M. Long, Shin Maeda, Anthony Wynshaw‐Boris, Zhi-Wei Li, Andrea L. Hevener and Roland M. Schmid. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.